| Nucleotide diversity analysis highlights functionally important genomic regions TV Tatarinova, E Chekalin, Y Nikolsky, S Bruskin, D Chebotarov, ... Scientific reports 6 (1), 35730, 2016 | 69 | 2016 |
| Reversal of infected host gene expression identifies repurposed drug candidates for COVID-19 J Xing, R Shankar, A Drelich, S Paithankar, E Chekalin, T Dexheimer, ... bioRxiv, 2020 | 32* | 2020 |
| Changes in biological pathways during 6,000 years of civilization in Europe E Chekalin, A Rubanovich, TV Tatarinova, A Kasianov, N Bender, ... Molecular biology and evolution 36 (1), 127-140, 2019 | 29 | 2019 |
| OCTAD: an open workspace for virtually screening therapeutics targeting precise cancer patient groups using gene expression features B Zeng, BS Glicksberg, P Newbury, E Chekalin, J Xing, K Liu, A Wen, ... Nature protocols 16 (2), 728-753, 2021 | 28 | 2021 |
| Integrated computational approach to the analysis of RNA-seq data reveals new transcriptional regulators of psoriasis A Zolotarenko, E Chekalin, A Mesentsev, L Kiseleva, E Gribanova, ... Experimental & molecular medicine 48 (11), e268-e268, 2016 | 23 | 2016 |
| Recent selection of candidate genes for mammal domestication in Europeans and language change in Europe: a hypothesis A Benítez-Burraco, E Chekalin, S Bruskin, T Tatarinova, I Morozova Annals of Human Biology, 1-8, 2021 | 12 | 2021 |
| Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma G Zhao, P Newbury, Y Ishi, E Chekalin, B Zeng, BS Glicksberg, A Wen, ... Acta Neuropathologica Communications 10 (1), 150, 2022 | 9 | 2022 |
| FRA1 mediates the activation of keratinocytes: Implications for the development of psoriatic plaques A Zolotarenko, E Chekalin, E Piruzian, S Bruskin Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (12 …, 2018 | 9 | 2018 |
| Positive Selection in Bifidobacterium Genes Drives Species-Specific Host–Bacteria Communication MS Dyachkova, EV Chekalin, VN Danilenko Frontiers in Microbiology 10, 484164, 2019 | 8 | 2019 |
| Identification of transcriptional regulators of psoriasis from RNA-Seq experiments A Zolotarenko, E Chekalin, R Mehta, A Baranova, TV Tatarinova, ... Biological Networks and Pathway Analysis, 355-370, 2017 | 7 | 2017 |
| Modern molecular genetic methods for age estimation in forensics AD Zolotarenko, EV Chekalin, SA Bruskin Russian Journal of Genetics 55, 1460-1471, 2019 | 6 | 2019 |
| Ibrutinib blocks YAP1 activation and reverses BRAF inhibitor resistance in melanoma cells SA Misek, PA Newbury, E Chekalin, S Paithankar, AI Doseff, B Chen, ... Molecular Pharmacology 101 (1), 1-12, 2022 | 4 | 2022 |
| Метилирование генов в CD3+-клетках при псориазе ВВ Соболев, ЕВ Денисова, АГ Соболева, ИМ Корсунская, ЕВ Чекалин, ... Российский журнал кожных и венерических болезней, 40-43, 2013 | 4 | 2013 |
| Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants J Xing, R Shankar, M Ko, K Zhang, S Zhang, A Drelich, S Paithankar, ... Iscience 25 (10), 2022 | 3 | 2022 |
| BGLM: big data-guided LOINC mapping with multi-language support K Liu, M Witteveen-Lane, BS Glicksberg, O Kulkarni, R Shankar, ... JAMIA open 5 (4), ooac099, 2022 | 2 | 2022 |
| Recent changes in candidate genes for domestication in humans in Europe: focusing on language A Benítez-Burraco, E Chekalin, S Bruskin, I Morozova bioRxiv, 684621, 2019 | 2 | 2019 |
| Computational discovery of co-expressed antigens as dual targeting candidates for cancer therapy through bulk, single-cell, and spatial transcriptomics E Chekalin, S Paithankar, R Shankar, J Xing, W Xu, B Chen bioRxiv, 2023.10. 17.562711, 2023 | | 2023 |
| Discovering novel bispecific antibody targets through the mining of large-scale bulk and single cell RNA-seq databases E Chekalin, S Paithankar, B Chen Cancer Research 82 (12_Supplement), 1198-1198, 2022 | | 2022 |
| IQGAP Genes in Psoriasis EV Chekalin, AD Zolotarenko, SA Bruskin Russian Journal of Genetics 56, 345-353, 2020 | | 2020 |
| Reversal of Infected Host Gene Expression Identifies Repurposed Drug Candidates for COVID-19 (preprint) J Xing, R Shankar, A Drelich, S Paithankar, E Chekalin, T Dexheimer, ... | | 2020 |
Bin ChenMichigan State UniversityVerified email at hc.msu.edu
